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PREFACE 
Social Sciences and Humanities (SSH) do not usually take a preeminent role in technical research 
projects. Sister projects arise as part of Horizon 2020 Framework Programme as a way to address 
this historical constraint and to allow SSH makes a meaningful contribution to the shaping of the 
research agenda. To this regard, Sister projects are created to go beside the mainstream research in 
order to challenge existing biases in the research agendas and trying out more daring alternatives 
through the widening of imaginaries and by taking into account the SSH perspective. 
CIFRA, as a Sister project, does not take the current status quo in the ICT patent ecosystem for 
granted, but on the contrary, explores the impact that potential new framings could have in ICT 
innovation and the value they could provide to the society. 
Moreover, CIFRA project has addressed the ICT Patent ecosystem from the perspective of the 
Responsible Research and Innovation (RRI), thus with the aim of determining the way it can be 
better aligned with the values, needs and expectations of society. 
1 INTRODUCTION 
This document analyses the different vision of the problems and solutions identified specifically on 
the deliverables D3.2_Report on Assessment of Impact of proposed new Framings for the patent 
system in other sectors beyond ICT. namely as the Health and Energy sectors.  We have selected 
these two sectors because both have interesting Patent Systems that appeared to us attractive to 
make a comparison with our main focus, the ICT. Health, and in particular Pharmaceutical sector, is 
one when the number of patents is concentrated and Energy because it entails important indirect 
and emergent activities that could lead to a new environment with a new system of patents 
comparison among the perceptions of these sectors of the main issues concerning the Patent 
System and the findings on ICT sector obtained from the first survey ran as part of the WP3 of CIFRA 
project. That first survey (https://inno.limequery.com/228186) was implemented with the aim of 
defining and prioritizing the main elements of possible changes of the current IPR system for the ICT 
sector.  
To carry out this specific comparison a second survey was launched, with the aim of comparing the 
different perceptions of innovation between the ICT and other sectors as Health or Energy. The 
survey was ran by email in two waves, a first launch in July 2017, in which not many responses were 
received, and then a second distribution between September and November 2017, obtaining a total 
of 14 responses, most of them from the health sector. 
In the following table we present the level of responses. 
Table – 1 : KPI´s Stakeholders 
Indicator KPI 
Total number persons contacted (ICT Vs Health sector survey) 42 
Total persons answered (ICT Vs Health sector survey) 14 
% of personas answered (ICT Vs Health sector survey) 30% 
 
Among the different intellectual property rights, the CIFRA project chose to focus on patents 
because patents are particularly relevant in ICT. We acknowledge upfront that findings might not be 
generalizable to other IPRs or industrial contexts. 
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2 PROJECTION BEYOND ICT SECTORS  
2.1 INTRODUCTION 
Based on the importance of patents for the promotion of responsible innovation and the awareness 
involved in the development and commercialization of patents and other intellectual property rights 
play we assert that patents in every sector play a different role. 
The results obtained from the literature review of WP2, the insights of deliverable D3.1 and the 
results of expert interviews and the focus groups, captured in deliverable D3.2 allowed to the CIFRA 
consortium identify the most relevant problems and potential solutions of the patent system in the 
ICT sector. This part of the study will replicated the survey ran for the ICT sector for the health and 
the energy sector. 
In the health R&D sector, the core scientific principles are to create technology and products aimed 
at treating diseases and the research progresses underlie functions of the human body. Treating 
diseases generally requires focusing on a specific biological mechanism, effectively limiting the 
number of substitute drugs. In this sector, even individual patents, may create a substantial impact, 
giving its owner a strong market position where it is granted. 
By contrast, the technology approaches to address problems as climate change have long been off-
patent and are already widely used. This happened because patents in the Energy Sector 
(Environmental Innovation) address efficiency and other incremental improvements of technology 
or features of existing solutions. Instead of unearthing entirely new approaches or technologies. For 
example, electricity generation by wind power was created in the late 19th century while the solar 
technology (photovoltaic) was discovered by the mid-20th century. Since then, both technologies´ 
patents constitute incremental improvements over the fundamental technologies. 
The level of competition in the energy technologies sector also differs dramatically from the 
pharmaceutical industry. In this latter industry the monopoly over a medicament may be exercised 
by a company owning a single patent. This is due to the fact that a single patent can protect a 
molecule, which may be the single active principle of a medicament, and which is not built on top of 
a previous innovation. In this case the level of competition is low, whenever other active principles 
have similar effect, or zero, whenever there is no reasonable alternative, and thus firms may have 
the market power to charge high prices for medicines or licensees. While, the patent ownership 
within clean energy technology segments themselves is generally distributed amongst numerous 
entities, each owning a subset of the technologies necessary to build an overall system, what limits 
the impact of each individual asset.  
The objective of this study is to compare the results of the review of the issues and possible 
improvements related to current framework for ICT patents with the view of health and energy 
sectors. As no previous study has been found that tackles the different visions by different sectors 
on the problems and solutions for the patent system, this study is based on the responses to the two 
surveys run as part of the CIFRA project. 
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2.2 HEALTH SECTOR 
It is known fact that patents are territorial rights and patent regimes are generally part of national 
technological and industrial strategies, but is also crucial to design them consistently with public 
health strategies. Patents over minor developments may be effectively used to discourage or block 
competition (e.g.  generic producers, purchasing agencies and consumers), especially in developing 
countries, which generally lack the substantial technical and financial resources needed to challenge 
wrongly granted patents or to defend against infringement claims. It is very important for branded 
pharma companies to obtain patent protection for their products in order to garner the investments. 
Therefore, it is widely acknowledged that patents are a fundamental incentive to innovative 
activities in pharmaceuticals and biotechnology industry. 
Patent protection for pharmaceutical products in the developing world can help to encourage the 
development of new medicines for diseases that affect these countries, by providing protection for 
the investments that need to be made by the pharmaceutical companies. Pharmaceutical companies 
often maintain that patent protection for drugs ensures that they are able to invest billions of dollars 
into the development of new products, by making sure that they will be able to take advantage of 
the sales. However, when the ideas that are being protected are medicinal drugs, this can be very 
controversial. Much of the controversy over pharmaceutical patents relate to the provision of drugs 
in the developing world. 
As in an article in Forbes in June 20171 claimed the tension between the individual inventor and the 
population over what constitutes a reasonable length of protection for intellectual property has 
played out in countries around the world for centuries. Ultimately, however, a patent is not an 
intrinsic or Constitutional right, but a conscious choice by governing bodies to grant the exclusive 
ownership of rights to innovators based, as mentioned, on what’s best for all of the citizens of the 
nation. 
Patents relating to pharmaceutical inventions 
A patent claim relating to a pharmaceutical product may relate to an active ingredient as such 
independently of or jointly with formulations, salts, prodrugs, isomers, etc., or cover any of these 
subject matters separately. It may also solely cover a manufacturing process or include both a 
process and a product. In some countries, as noted below, use-related claims are admissible.  
It is important to bear in mind that while the development of new molecules of pharmaceutical use 
may encompass various levels of inventive steps, pharmaceutical techniques for the preparation of 
medicines in different forms and dosages are generally well known and part of the pool of 
knowledge in possession of a ‘person skilled in the art’. Hence, there is a narrow range of 
developments that could be considered genuinely inventive in this field in view of the state of the 
art. 
Patents relating to formulations and compositions 
The same active ingredient may be presented in different dosage forms, for instance, as tablets, 
capsules, ointment or aqueous solutions for parenteral administration, which in turn can be 
formulated using different pharmaceutically acceptable excipients. A large number of patents claim 
                                                          
1 Dr. Robert Pearl is the bestselling author of "Mistreated: Why We Think We're Getting Good Health Care--And Why We're 
Usually Wrong" and a Stanford University professor. 
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formulations of new or existing drugs, often including specifications of dose or concentration, either 
as the principal claim or in subordination to claims over the active ingredients or their uses. 
‘Composition claims’ cover active ingredients and pharmaceutically acceptable carriers or excipients, 
such as fillers, binders, disintegrates and lubricants. Finally, it should be noted that processes to 
prepare formulations or compositions are generally well known and routinely applied. Hence, claims 
over such processes would rarely be inventive. 
2.3 ENERGY SECTOR 
Innovation in energy technologies tries to address problems like climate change, renewable energy, 
and energy security. Energy technology is complex as on the ICT sector, companies may specialize in 
manufacturing one or several components, while others companies from other industries may try to 
adapt to their existing technologies to novel applications. For example, in the wind turbine 
technologies, patenting is concentrated on the use of improved materials and sensors that can allow 
longer product life-cycles and decreased system costs, while for the enzyme-based carbon the 
patenting is concentrated in obtaining better separation methods that can be traced to advances in 
the biotech industry. 
In fact, the energy sector mix technologies from a diverse range of sectors of the economy which are 
employed in the extraction, conversion, and end-use of energy. Therefore, most energy innovations 
are not only developed by energy companies in the way that it is required a collaboration of other 
sectors in order to construct a specialized technology, such as: semiconductors (solar panels), 
electro-mechanical machinery (gas turbines), agriculture (biofuel feedstocks), and biochemistry 
(biofuel conversion technology). The role of patents in Renewable Energy Technology (RET) 
innovation still needs to be better understood. They can support the development of national 
policies and regulations, but this requires further clarification and understanding about the positive 
role they can play, the effectiveness of their use and the information they contain. 
In the case of RET, further analysis is still required to assess the impact of patents on the innovation 
and commercialization rate of technologies. Renewable energy accounts for only a small proportion 
of total patenting activities. The characteristics of RET, notably the rate at which the market 
develops in comparison to the 20-year term of patents and the global activities of many equipment 
suppliers, mean that patents do not create a major barrier for the deployment of RET.  Patents are a 
measure for research output. They can contain valuable information for the development of new 
technologies before a market takes off. However, there are some limitations to patent information. 
Licensing may be a better proxy for technology transfer and dissemination, yet information on 
licensing is often kept confidential. Different patent databases based on different classification 
schemes provide different results in searching. The users of patent information need to be informed 
of, and understand, these limitations. There are more than 200,000 patents in the area of renewable 
energy. Only in hindsight is it usually possible to identify which ones are key patents. Patenting in 
most renewable energy areas has increased more than five-fold in the last two decades. Many 
patents in solar PV and wind were filed 10-15 years ago and are reaching the end of their terms, 
unless they have not been abandoned or revoked in the countries where they applied. This means 
the information can soon be freely used, and may already be available for use in locations where 
patent protection was not sought. In any case the filings were usually limited to key markets, and 
very few renewable energy patents have been filed outside OECD countries and China. This means 
that patents in the renewable energy sector should be considered as a source of innovation for 
developing countries, not as a constraint to innovation. 
Managing climate change requires driving technology with heavily investment for the private sector. 
In 2009 sixty percent of the total investment on clean energy technology R&D (29billons) was 
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privately financed (UNEP SEFI). Europe exhibits a higher dependence on industry investment, 
providing nearly seventy percent of the region’s clean energy R&D funding (UNEP SEFI 
Intellectual Property Rights (IPRs) are a key instrument for the energy private sector engagement 
which requires strong and predictable IPR protection as a pre-requisite to invest in low carbon and 
energy efficient technology.  
Increasing patent quality will enhance the utility of patents as a source of technical information. 
Governments should ensure that applications examined by their patent offices are of the highest 
possible quality.  Renewable energy patent information can provide valuable insights into: 1) which 
countries and innovators are active in inventing technologies, 2) which countries are the potential 
markets where technologies need to be protected, 3) the trends of technology developments in 
certain technology fields over time, 4) the trends of technology transfers from one country to 
another and 5) international research and co-operation as indicated by co-invention and co-
ownership. 
2.4 METHODOLOGY 
The survey for the Health and the Energy sector has been structured by modifying the finale 
ICT stakeholder survey constructed on the D.3.2 Report on Assessment of Impact of 
proposed new framing of the CIFRA project. 
The modifications were made as the following: first, we maintained the most generic 
questions related with the organization structured and the uses of the Intellectual Property 
Rights, in order to understand the level of R&D activity run in their companies and to measure 
how these sectors compete in terms of innovation.  
Then we analyzed which challenges and problems can be of greater importance in sectors 
beyond ICT. So we followed the mayor proposals for the specifics changes on the current 
patent system presented. By only keeping the main points for granting effectiveness to 
promote innovation, challenges for the patent offices and the possible solution. We didn’t 
take into account the questions which where specifics for the ICT sector, as the ones related 
with computer and software challenges. 
Nevertheless, we kept the series of question provided to better understand how the sectors 
are implementing the Research, Responsible Innovation (RRI) regarding to the patents. In 
annex-1 we include the survey that was carried out. 
Once we constructed the new survey, the distribution process was run by email between July 
and November.  Where the target audience was power-technology companies for the Energy 
sector, while for the health sector were Pharma laboratories, research centers and companies. 
We sent in total 34 surveys. 
The main problem faced in this part of the project was the lack of responses by the 
stakeholders. On the first try to obtain answered surveys we couldn’t reach the minimum 
expected. The total responses were three. Despite the fact that the low number of responses, 
we ran a second wave of emails to the previously contacted companies and adding 8 more 
recommended companies’ contacts.  Nevertheless, the result of this process was a total of 14 
full answered surveys. 
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2.5 EMPIRICAL ANALYSIS 
The main purpose of this deliverable is to assess the comparison among behaviors of different 
sectors related to patents. To better understand each sectors we compared the results obtained 
from the survey in D3_2_Report on Assessment of Impact of proposed new Framings with results 
obtained in the surveys of the health and energy sectors. 
The Innovation activity across companies in the 3 sectors is based on the uses of Intellectual 
Property Rights (IPR). In the ICT and Health sector the large share of innovation (80% and 68% 
respectively) are concentrated in the introduction of new products to the market. While in the 
Energy sector the share is significant higher in the process and in the Organization innovation. 
Nevertheless, the three sectors are less interested to innovate in the marketing process.  
 
 
 
Figure 1 Percent of companies by Innovation type per sector 
 
Source: own construction from survey responses 
 
Analyzing the type of protection that each sector is willing to use for their intangibles, the energy 
sector, accounts by 50 percent of patenting activity, followed by the trademarks protection while 
obtain a utility model is less (>10%). Furthermore, their process innovation patents are anchored to 
address efficiency and other incremental improvements of technology more than to introduce 
products. Whereas, in the ICT sector the share for patent activity is even higher but it is also 
concentrated to registered trademarks and claimed copyright. On the other hand, in the health 
sector protect their innovation by patent is almost the same proportion than the uses of trademarks. 
This happened because the commercial success of brands has become a key driver of corporate 
strategy for pharmaceutical companies.  The need for rigorous patent protection remains important 
and impulse by the spotlight is increasingly on trademarks. 
 
Figure 2 Percent of companies using Intellectual Property Right per sector 
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Source: own construction from survey responses 
 
Taking into account the differences between each sectors, we analized the monetization strategies. 
The Health sector is characterised by having in many cases a univocal correspondence between a 
single patent and a product and by a dependency between the pharmaceutical, chemical and the 
biotechnology industries. These three industries are much different than other patenting industries 
such as computers and electronics (ICT) and Energy, these two sectors are characterized by 
extensive use of other techniques for managing inventions, including the use of trade secrecy and 
the pooling of patents with those of competitors to accommodate government and industry 
technical standards.  
Nevertheless, we obtained more representative figures on the proportion of licensing patent. 
Licensing may be a better proxy for technology transfer and dissemination. In our sample we asked 
whether the patent-holding firms engaged in out-licensing at all to another companies or 
organizations in return of a reward or financial benefit.  According to the survey responses the 
energy and health industries have a high rate of licensing out activity. Respectively 100% and 70% of 
the firms said in the survey that they currently do. The patented products of pharmaceutical 
companies can be easily and cheaply replicated by copiers with little capital investment, so patent 
exclusivity is the only effective way to protect and receive a return on that investment. 
Conversely, by licensing – in the both sectors are able to increase the market penetration and be 
able to sell their services or products in other territories. Also to reduce the R&D cost and to save 
time in the introduction of new products on the high competition market concentration.   
 
Figure 3 Percent of companies willing to be part of the licensing activity per sector 
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.  
Source: own construction from survey responses 
 
Perhaps the most striking finding is the ICT sector overall has the lowest values. This result may have 
variations because the proportion of number of surveys runs by sector (where the ICT has the largest 
number of responses).  
2.5.1 Effectiveness of patents  
After understanding how the companies in the three sectors protect their innovation and monetized 
them, we established a reference point in order to be able to assess the problems identified in the 
patent system, is to compare the effectiveness of patents in their companies. 
The differentiation of the responses depends on a company’s business model. Overall, the 
importance of protection from imitation of invention achieves is higher for the energy and health 
sectors than the ICT, as we explained before, patented of pharmaceutical companies can be easily 
and cheaply replicated with little capital investment. Nevertheless, effectiveness of patents in 
blocking competitors is small for the health companies, due to this sector is willing to license more. 
By contrast the aggressive patenting strategy to block new developments and protect its strong 
market position it’s been growing for the ICT sector. Maybe due to the accelerated grow up of the 
number of patents in the last decade. 
The licensing generates revenues via patents are ranked lowest for the heath sector despite there is 
the sector with highest rate of licensing. In the other hand, the ICT and the energy sector find 
effectiveness to license to obtain revenues. 
However, using patents to enhance the own reputation and to measure performance is ranked the 
highest for the energy sector, while are above medium effectiveness for the other two sectors. 
Which also is aligned with the finding of Blind et al. (2011) of using patents for signaling own 
technological competencies. 
 
Figure 4 Effectiveness of patents ranging from very low (1) to very high (5) 
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Source: own construction from survey responses 
 
2.5.2 Challenges for patents 
Some of the most relevant problems and potential solutions identified in the literature were 
presented in Deliverable D3.2. Based on those results we compare with other sectors experiences. 
The three sectors have the same perception of   costs for applying patents. For them is not a 
problem invest in protect their innovation, large companies have resources reserved for these 
expenses.  Furthermore, the granting process for Energy and ICT patents are obviously more 
complex due to the technological dynamics while for the health sector this is not an issue as long as 
they can have the patent. 
The requirement of collaboration between sectors to construct a specialized technology, increase 
the dependency of ICT technology (energy and health sector especially). So, the large quantity of 
patents application on the ICT generated challenges on evaluated the quality of those patents. 
Nevertheless, the current state of the art is more difficult to identify due to the dynamic ICT 
technologies. On the other hand, in the health sector is more difficult to grant a low quality patents 
because getting a primary patent in this sector is more complex, since almost all the products are for 
patients and have to be tested before they are released on the market. Nevertheless, by strategy 
pharmaceutical firms tended to using secondary patents to extend periods of exclusivity. This was 
generating concerns among policymakers worldwide due to the fact that were doubts of the quality 
of those patens. In response, some developing countries have introduced measures to curb the 
grant the secondary patents.  
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The assessment of the adequate length of the protection period for patents reveals that the current 
maximum length of twenty years for the Health sector is appropriate even if in the pharmaceutical 
industry emphasizes very early disclosure of inventions, usually long before a resulting product can 
be placed on the market., In fact the pharmaceutical sector as we explained before relies on 
secondary patents to extent the periods of protection.. In the other hand in the other two sectors 
inventions can be kept like trade secret until the moment they are marketed, this option enables the 
companies to delay the patent filings until the last possible moment and maximize the effect of the 
20 year patent term  
Another important fact, is that, unlike sectors as energy or ICT, the health sector is heavily regulated 
by government agencies to assure the safety and efficacy of products which will be sold to 
consumers. Nevertheless, the investment in new drugs needs to pass some the clinical trials which 
are necessary to satisfy safety and efficacy regulators.  
Another challenge can be the language used for health and ICT patents is perceived problematic. In 
both sector the tendency to keep the claims as generic as possible is higher. 
The challenges in terms of litigation and Patent Assertion Entities (PAE) are related. While the PAEs, 
are divided in good ones fostering licensing for the re-appropriation of R&D investments and bad 
ones using the cost of litigations to push the price for licenses. In several interviewees we confirm an 
increase interest in the litigation activity driven by the phenomenon of overlapping claims. 
Nevertheless, are still much more relevant in the ICT sector than in the energy and health sectors 
have less. 
Figure 5 Assessment of the challenges for patents regarding patent enforcement and application 
ranging from totally disagree (1) to totally agree (5) (patent owners (yes) vs non-patent owners 
(no)) 
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Source: own construction from survey responses 
 
2.5.3 Solutions  
We developed a set of possible solutions focus on the success of patent application and the 
enforcement and implementation of patents.  
The effectivity in the successful of patent application is focuse on: raising the quality of  patents. 
Indeed, the patents system should have appropriate policies and examination procedures to 
harmonized approach to high-quality patents. Also, the three sectors have the same perception on 
raising the costs for patent applications or renewals of granted patents are not perceived to be very 
effective. According to some interviewees, higher application fees would distract patents of low 
quality. Furthermore, this instrument will not being effective in raising patent quality. It is clear that 
the above changes will provide efficiencies for the patents offices,  not only in terms of cost but on a 
broader, practical level. 
In terms of halving the patent protection period the majority of interviews see no need to restrict 
the protection period despite the high dynamics in ICT and energy sector. 
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Figure 6 Assessment of solutions for patents promoting innovation regarding patent application 
and granting ranging from not effective (1) to very effective (4) 
 
Source: own construction from survey responses 
 
However, we analyzed solutions focus on facilitating the licensing of patents. And the proposals to 
solve conflicts both within and outside courts easier. 
The health and ICT sector have the same perception in the activity of licensing the rights throught 
patent pledges and regulation to restrict PAEs, not only as institutions and as part of the system to 
increase market transparency and efficiency, but also a source to generate revenues for financing 
R&D. Another intertesting instrument is the declaration of willingness to grant a license for 
commercial use to anyone (L.O.R.)  because it is proposed to reward companies  by reducing the 
maintenance fees, especially for older patents, and by expanding the patent protection period. 
The  proposed solutions related to patents disputes in specialized courts in order to deal only with 
patent disputes including both questions of patent validity and infringement are higher for the 
health sector than the others. 
 
2.5.4  Assessment of RRI dimensions 
According to the European Commission, “Responsible research and innovation (RRI) is an approach 
that anticipates and assesses potential implications and societal expectations with regard to 
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research and innovation, with the aim to foster the design of inclusive and sustainable research and 
innovation.”  
Figure 7 The use of Intellectual Property Right by sector 
 
Source: own construction from survey responses 
 
We first asked about the importance of the multi-actors and public engagement, which, in general 
terms, implies the ways to engage the society broadly in the research and innovation activity. The 
answers in the three sector are scattered. In one hand, the innovation in the energy sector currently 
is focus in ensuring the operations by carrying out an environmentally responsible manner. 
furthermore, the public support to reduce the global warming emission of greenhouse gases allows 
to achieve sustainability targets by funding incentives.  
As we can see form the figure, Energy sector considers that all issues to encourage the use of 
Intellectual Property Rights are highly important with respect ICT or health sectors. With the 
exception of gender, that all agree on low effect, ICT and Energy sectors would like to enable higher 
access to scientific results and a major presence of other actors in the implementation of R&D.  
To ensure basic human rights are respected, that products will be developed in accordance with 
trade principles that are fair and that recognise the rights of people to just reward (including labour 
rights and intellectual property rights) and that costs and benefits are equitably distributed. We 
analyzed the importance of the ethical considerations.The health and energy plays more important 
role that in ICT.  Nevertheless, to benefit the society and human wellbeing the healthcare industry 
applies life- enhacing products such a medicines and equipments. Also the ways that the companies 
are testing the innovations in this sector has been controled since decades ago. However, since the 
techonology is allowing them to  improve processes, now there is a new concern in the society bases 
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on the personal information (data protection). The energy sector, also has a huge government 
incentives to support and improve the enviromental innovation (green transport, waste 
minimalization, improve efficiancy).According to our findings, the three sectors are aware of the 
importance of training their employees in the RRI dimensions and to create projects more focused in 
RRI. Perhaps the societal challenge generated by emerging technologies is higher for the energy and 
ICT sector, whilst the health sector and the pharmaceutical industry have more experience in dealing 
with the improvement of societal welfare. 
2.6 CONCLUSIONS 
This report aims at identifying the different perspectives and opinions beyond the ICT sector about 
the current challenges and proposed solution for patents system presented in CIFRA’s deliverable 
D3.2, based on the insights of the literature review and the empirical analysis performed in Work 
Package 2. 
The only problems identified as highly relevant by all three sectors are: the slow process to obtain a 
patent grant and the lack of willingness to license some patents. Thus, the perception of other 
problems such as patent quality, the patent protection period and litigation are different for each of 
the sectors. Taking into account the identified problems, we have assessed the appropriateness of 
some of the solutions. In this case, the three sectors agree in the importance of the Patent Offices in 
the process of ensuring the level of quality of the innovation, the increase on the maintenance fees 
in order to promote innovation and reduce low quality patents. 
The short number of responses recevied from the Health and Energy sector, made it challenging to 
compare the results with the ICT sector. Nevertheless, we have identified some clear particularities 
for the different sectors. We can conclude that patents play a key role as an engine for innovation 
and as a source of information regarding innovation trends in R&D intensive sectors, such as 
pharmaceutics. Making patent information more accessible may help to accelerate innovation. 
Patent information can be made more accessible and easy to understand, for example through 
translations and a user-friendly information platform. 
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ANNEX-1: Survey per the health and energy sector 
Contact data: 
Please give us some information (confidentiality is guaranteed), which allow us to send you the 
summary of the results. 
mail address 
mpany Name 
untry 
0. Position of the person answering the questionnaire 
Please indicate your position or responsibility in your company 
Chief Executive Officer (top management) ☐
Member of Legal/Patent Department ☐
Member of R&D Department ☐
Other position ☐
Please specify:_______________________ 
1. Basic economic information about your company 
What is your company's core business or primary sector of activity? 
What is your company's core business model? 
Business model of your company (multiple answers possible) 
Company producing final consumer products ☐
Company supplying components ☐
Research institute (Private) ☐
Research institute (Semi-Public) ☐
Service company ☐
Other business model: ☐
2. Innovation Activity
During the 2014-2016 period, your company introduced any type of innovation, that is, a 
product, service, process (technology), marketing or organizational method, which is new or 
significantly improved? 
Tipo de innovación No Si 
Innovación de producto ☐ ☐
Proceso de innovación ☐ ☐
Innovación en marketing ☐ ☐
Innovación organizacional ☐ ☐
3. Use of Intellectual Property Rights
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Did your company make use of the following intellectual property rights between 2014 and 
2016 and if so, please provide an approximate number? 
Intellectual Property Rights No Yes Approx. Number 
Application of Patents ☐ ☐
Application of Utility Patents ☐ ☐
Registration of Industrial Designs ☐ ☐
Registration of Trademarks ☐ ☐
Enforcement of Copyrights ☐ ☐
Others ☐ ☐
Did your company license out or sell own patents or license in patents of third parties? 
Licensing No Yes Approx. Number 
Own patents rights licensed out or sold to third parties ☐ ☐
Patents of third parties licensed in /bought (excl. standard software) ☐ ☐
Others ☐ ☐
4. Factors hampering innovation
Your activities to develop and introduce innovations into the market could be hampered by 
various factors. Please grade the importance of the following hampering factors for your 
company during the period 2014-2016. 
Hampering factors Importance 
very 
low 
low medium high very 
high 
Perceived excessive economic risks ☐ ☐ ☐ ☐ ☐
Innovation costs too high ☐ ☐ ☐ ☐ ☐
Not feasible from a scientific/technical point of view ☐ ☐ ☐ ☐ ☐
Lack of appropriate sources of financing ☐ ☐ ☐ ☐ ☐
Internal rigidities within the company ☐ ☐ ☐ ☐ ☐
Lack of information on technology ☐ ☐ ☐ ☐ ☐
Lack of information on markets ☐ ☐ ☐ ☐ ☐
Governmental regulations (i.e. directives, laws) ☐ ☐ ☐ ☐ ☐
Problems with access to intellectual property rights of other 
companies/organisations 
☐ ☐ ☐ ☐ ☐
Others, please specify: _____________________ ☐ ☐ ☐ ☐ ☐
5. Assessing the effectiveness of patents from your company’s perspective
Please assess the effectiveness of patents for achieving the following objectives to apply patents. 
Assessment of effectiveness 
Objectives Very 
low 
Low Medium High Very 
high 
No 
assessment 
Preventing unintended copying of inventions ☐ ☐ ☐ ☐ ☐ ☐
Blocking competitors ☐ ☐ ☐ ☐ ☐ ☐
Using in negotiations (incl. cross licensing) ☐ ☐ ☐ ☐ ☐ ☐
Generating licensing revenues ☐ ☐ ☐ ☐ ☐ ☐
Enhancing reputation ☐ ☐ ☐ ☐ ☐ ☐
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Measuring performance ☐ ☐ ☐ ☐ ☐ ☐
6. Assessment of the challenges for patents related to innovation in your company
Please assess the following challenges for patents in relation to innovation including research 
and development. 
Assessment 
Challenges for innovation totally 
disagree 
disagree ambivalent agree totally 
agree 
No 
assessment 
The cost for applying for patents is 
too high 
☐ ☐ ☐ ☐ ☐ ☐
The granting process for patents is 
too slow  
☐ ☐ ☐ ☐ ☐ ☐
The language of patents is too 
complicated to qualify as a good 
source of knowledge 
☐ ☐ ☐ ☐ ☐ ☐
The quality of patents granted by the 
European Patent Office is low 
☐ ☐ ☐ ☐ ☐ ☐
The maximum protection period of 
20 years is long for patents 
☐ ☐ ☐ ☐ ☐ ☐
The likelihood of litigation 
(infringement) of patents is high 
☐ ☐ ☐ ☐ ☐ ☐
Expected legal cost for settlements of 
conflicts related to  patents at court 
are high 
☐ ☐ ☐ ☐ ☐ ☐
Licensors are not willing to license 
patents covering their inventions 
(hold-up) 
☐ ☐ ☐ ☐ ☐ ☐
Large patent owners not joining pools 
of patents challenges the 
implementation of technology 
☐ ☐ ☐ ☐ ☐ ☐
The use of patents by Patent 
Assertion Entities (PAEs) challenges 
innovation  
☐ ☐ ☐ ☐ ☐ ☐
7. Assessment of solutions to patents 
Several solutions are currently being discussed to improve the present framework relevant for 
patents. Which of the following approaches are suitable to make the framework for patents 
more conducive to innovation?  
Effectiveness for innovation 
Possible solutions not 
effective 
ambivalent effective very 
effective 
cannot be 
assessed 
The application fees for patents are raised ☐ ☐ ☐ ☐ ☐
The quality of granted patents is 
improved by raising the required degree 
of novelty 
☐ ☐ ☐ ☐ ☐
The quality of granted patents is 
improved by raising the required 
inventive step 
☐ ☐ ☐ ☐ ☐
The renewal fees for granted patents are 
increased 
☐ ☐ ☐ ☐ ☐
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The protection period for patents is 
shortened to 10 years 
☐ ☐ ☐ ☐ ☐
The declaration of willingness to grant a 
licence to anyone (licence of right L.O.R.) 
is required to receive the maximum of 20 
year of patent protection 
☐ ☐ ☐ ☐ ☐
Defining a set of well-known and trustable 
patent pledges, i.e. voluntary 
commitments by patent holders to give 
up some of the rights associated to the 
patent (e.g. grant permission to use 
without any direct compensation, no 
injunctions, FRAND, etc) 
☐ ☐ ☐ ☐ ☐
Regulations to restrict the activities for 
Patent Assertion Entities (PAEs) are 
established 
☐ ☐ ☐ ☐ ☐
Mediation and arbitration processes to 
reach a mutually satisfactory settlement 
of patent disputes outside of court are 
further publicly supported (or 
mandatory?) 
☐ ☐ ☐ ☐ ☐
Special courts instead of general courts 
should deal with patent disputes 
☐ ☐ ☐ ☐ ☐
8. Assessment of RRI dimensions related to patents
Please specify the five dimensions of implementing Responsible Research and Innovation (RRI) 
and assess their relevance of related to patents. 
Relevance 
RRI Dimensions Very 
low 
Low Medium High Very 
high 
cannot be 
assessed 
Multi-actor and public engagement in research 
and innovation: 
☐ ☐ ☐ ☐ ☐ ☐
Enabling easier access to scientific results: ☐ ☐ ☐ ☐ ☐ ☐
Gender issues the research and innovation 
content and process: 
☐ ☐ ☐ ☐ ☐ ☐
Ethics in the research and innovation content 
and process: 
☐ ☐ ☐ ☐ ☐ ☐
Formal and informal science education: ☐ ☐ ☐ ☐ ☐ ☐
